Contributions and challenges of community pharmacists during the COVID-19 pandemic: a qualitative study

References

• WHO Director-General’s opening remarks at the media briefing on COVID-19–11 March 2020. https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020. Accessed 24 Sep 2021.
   Google Scholar
• Perlini S, Canevari F, Cortesi S, et al. Emergency department and out-of-hospital emergency system (112-AREU 118) integrated response to Coronavirus Disease 2019 in a Northern Italy centre. Intern Emerg Med. 2020;15(5):825–833 https://doi.org/10.1007/s11739-020-02390-4.
   PubMed Web of Science ®Google Scholar
• Kerlin MP, Costa DK, Davis BS, Admon AJ, Vranas KC, Kahn JM. Actions taken by US hospitals to prepare for increased demand for intensive care during the first wave of COVID-19: a national survey. Chest. 2021;160(2):519–528. https://doi.org/10.1016/j.chest.2021.03.005.
   PubMed Web of Science ®Google Scholar
• Haldane V, Zhang Z, Abbas RF, et al. National primary care responses to COVID-19: a rapid review of the literature. BMJ Open. 2020;10(12):e041622. https://doi.org/10.1136/bmjopen-.2020-.041622.
   PubMed Web of Science ®Google Scholar
• Watson KE, Van Haaften D, Horon K, Tsuyuki RT. The evolution of pharmacists’ roles in disasters, from logistics to assessing and prescribing. Can Pharm J (Ott). 2020;153(3):129–131. https://doi.org/10.1177/1715163520916921.
   PubMedGoogle Scholar
• Watson KE, Singleton JA, Tippett V, Nissen LM. Defining pharmacists’ roles in disasters: A Delphi study. PLoS ONE. 2019;14(12):e0227132. https://doi.org/10.1371/journal.pone.0227132.
   PubMed Web of Science ®Google Scholar
• Miller S, Patel N, Vadala T, Abrons J, Cerulli J. Defining the pharmacist role in the pandemic outbreak of novel H1N1 influenza. J Am Pharm Assoc. 2012;52(6):763–767. https://doi.org/10.1331/JAPhA.2012.11003.
   Google Scholar
• Wisner B, Adams J, World Health Organization. , Environmental health in emergencies and disasters: a practical guide. Geneva:World Health Organization;2002.
   Google Scholar
• International Pharmaceutical Federation. COVID-19 guidance: guidelines for pharmacists and the pharmacy workforce. 2020. https://www.fip.org/files/content/priority-areas/coronavirus/COVID-19-Guidelines-for-pharmacists-and-thepharmacy-workforce.pdf. Accessed 24 Sep 2021.
   Google Scholar
• Todd A, Copeland A, Husband A, Kasim A, Bambra C. The positive pharmacy care law: an area-level analysis of the relationship between community pharmacy distribution, urbanity and social deprivation in England. BMJ Open. 2014;4(8):e005764–e005764. https://doi.org/10.1136/bmjopen-2014-005764.
   PubMed Web of Science ®Google Scholar
• International Pharmaceutical Federation. COVID-19 guidance (Part 2): guidelines for pharmacists and the pharmacy workforce. 2020. https://www.fip.org/file/4729. Accessed 24 Sep 2021.
   Google Scholar
• Ministère des Solidarités et de la Santé. Arrêté du 26 octobre 2020 modifiant l’arrêté du 10 juillet 2020 prescrivant les mesures d’organisation et de fonctionnement du système de santé nécessaires pour faire face à l’épidémie de covid-19 dans le cadre de l’état d’urgence sanitaire. 2020. https://www.legifrance.gouv.fr/jorf/id/JORFTEXT000042469123. Accessed 24 Sep 2021.
   Google Scholar
• Ministère des Solidarités et de la Santé. Décret n° 2021–248 du 4 mars 2021 modifiant les décrets n° 2020–1262 du 16 octobre 2020 et n° 2020–1310 du 29 octobre 2020 prescrivant les mesures générales nécessaires pour faire face à l’épidémie de covid-19 dans le cadre de l’état d’urgence sanitaire - Légifrance. 2021. https://www.legifrance.gouv.fr/jorf/id/JORFTEXT000043216584. Accessed 24 Sep 2021.
   Google Scholar
• Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349–357. https://doi.org/10.1093/intqhc/mzm042.
   PubMed Web of Science ®Google Scholar
• Gale NK, Heath G, Cameron E, Rashid S, Redwood S. Using the framework method for the analysis of qualitative data in multi-disciplinary health research. BMC Med Res Methodol. 2013;13(1):117. https://doi.org/10.1186/1471-2288-13-117.
   PubMed Web of Science ®Google Scholar
• Saha SK, Hawes L, Mazza D. Effectiveness of interventions involving pharmacists on antibiotic prescribing by general practitioners: a systematic review and meta-analysis. J Antimicrob Chemother. 2019;74(5):1173–1181. https://doi.org/10.1093/jac/dky572.
   PubMed Web of Science ®Google Scholar
• Wu JHC, Khalid F, Langford BJ, et al. Community pharmacist prescribing of antimicrobials: A systematic review from an antimicrobial stewardship perspective. Can Pharm J (Ott). 2021;154(3):179–192. https://doi.org/10.1177/1715163521999417.
   PubMedGoogle Scholar
• Watson KE, Schindel TJ, Barsoum ME, Kung JY. COVID the catalyst for evolving professional role identity? A scoping review of global pharmacists’ roles and services as a response to the COVID-19 pandemic. Pharmacy (Basel). 2021;9(2):99. https://doi.org/10.3390/pharmacy9020099.
   PubMedGoogle Scholar
• Paudyal V, Cadogan C, Fialová D, et al. Provision of clinical pharmacy services during the COVID-19 pandemic: experiences of pharmacists from 16 European countries. Res Social Adm Pharm. 2020. https://doi.org/10.1016/j.sapharm.2020.11.017.
   PubMed Web of Science ®Google Scholar
• Isenor JE, Edwards NT, Alia TA, et al. Impact of pharmacists as immunizers on vaccination rates: a systematic review and meta-analysis. Vaccine. 2016;34(47):5708–5723 https://doi.org/10.1016/j.vaccine.2016.08.085.
   PubMed Web of Science ®Google Scholar
• Santé Publique France. COVID-19 : point épidémiologique du 4 mars 2021. https://www.santepubliquefrance.fr/maladies-et-traumatismes/maladies-et-infections-respiratoires/infection-acoronavirus/documents/bulletin-national/covid-19-point-epidemiologique-du-4-mars-2021. Accessed 24 Sep 2021.
   Google Scholar